MEDIVEN ESPRIT Trademark
Serial Number: 79350045 • Registration: 7245101
MEDIVEN ESPRIT is a trademark filed by
MEDI GMBH & CO. KG
on August 3, 2022. The trademark is classified under Class 10 (Medical Apparatus).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
James L. Lester MacCord Mason PLLC
2733 Horse Pen Creek Rd.
Suite 101
Greensboro
NC 27410
Trademark Details
Filing Date
August 3, 2022
Registration Date
December 19, 2023
Published for Opposition
October 3, 2023
Filing History
NEW REPRESENTATIVE AT IB RECEIVED
Aug 16, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 23, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 2, 2024 FICS
FINAL DISPOSITION PROCESSED
Apr 2, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 19, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 19, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 19, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Oct 4, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 3, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 3, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 13, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 13, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 13, 2023 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Aug 15, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 2, 2023 CNSA
REFUSAL PROCESSED BY IB
Jul 26, 2023 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 21, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 21, 2023 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 6, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jul 6, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 24, 2023 RFCR
NON-FINAL ACTION WRITTEN
May 23, 2023 CNRT
ASSIGNED TO EXAMINER
May 22, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 24, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 20, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 16, 2022 REPR
